VEGFA and cholesteatoma: Therefore, we suggest that TIMP-2 intercorrelates with VEGF in cholesteatoma tissue and that reduced relative numbers of TIMP-2 mean reduced anti-angiogenetic properties in cholesteatoma tissue, which results in increased neo-angiogenesis.